Literature DB >> 24721314

Synthesis, crystal structures and characterization of late first row transition metal complexes derived from benzothiazole core: anti-tuberculosis activity and special emphasis on DNA binding and cleavage property.

Priya P Netalkar1, Sandeep P Netalkar1, Srinivasa Budagumpi2, Vidyanand K Revankar3.   

Abstract

Air and moisture stable coordination compounds of late first row transition metals, viz. Co(II), Ni(II), Cu(II) and Zn(II), with a newly designed ligand, 2-(2-benzo[d]thiazol-2-yl)hydrazono)propan-1-ol (LH), were prepared and successfully characterized using various spectro-analytical techniques. The molecular structures of the ligand and nickel complex were unambiguously determined by single-crystal X-ray diffraction method. The [Ni(LH)2]Cl2.3H2O complex is stabilized by intermolecular CH⋯π stacking interactions between the methyl hydrogen and the C18 atom of the phenyl ring (C11-H11B⋯C18) forming 1D zig-zag chain structure. Both, the ligand and its copper complex, were electrochemically active in the working potential range, showing quasi-reversible redox system. The interactions of all the compounds with calf thymus DNA have been comprehensively investigated using electronic absorption spectroscopy, viscosity, electrochemistry and thermal denaturation studies. The cleavage reaction on pBR322 DNA has been monitored by agarose gel electrophoresis. The results showed that the ligand can bind to CT-DNA through partial intercalation, whereas the complexes bind electrostatically. Further, [Ni(LH)2]Cl2.3H2O and [CuLCl(H2O)2] complexes in the series have high binding and cleavage affinity towards pBR322 DNA. Additionally, all the compounds were screened for anti-tuberculosis activity. All the complexes revealed an MIC value of 0.8 μg/mL, which is almost 8 times active than standard used (Streptomycin, 6.25 μg/mL).
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DNA binding; NNO donor ligand; Transition metal complex; X-ray diffraction

Mesh:

Substances:

Year:  2014        PMID: 24721314     DOI: 10.1016/j.ejmech.2014.03.083

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Structural analysis and biological functionalities of iron(III)- and manganese(III)-thiosemicarbazone complexes: in vitro anti-proliferative activity on human cancer cells, DNA binding and cleavage studies.

Authors:  Büşra Kaya; Zehra Kübra Yılmaz; Onur Şahin; Belma Aslim; Ümmügülsüm Tükenmez; Bahri Ülküseven
Journal:  J Biol Inorg Chem       Date:  2019-03-20       Impact factor: 3.358

2.  New Quinoline-Urea-Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling.

Authors:  Rashmika Moodley; Chakes Mashaba; Goitsemodimo H Rakodi; Nomagugu B Ncube; Mabuatsela V Maphoru; Mohammed O Balogun; Audrey Jordan; Digby F Warner; Rene Khan; Matshawandile Tukulula
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-05

3.  Transition metal(II) complexes of a novel symmetrical benzothiazole-based ligand: synthesis, spectral/structural characterization and fluorescence properties.

Authors:  Mehmet Gulcan; Yaşar Karataş; Sema Işık; Gülsiye Öztürk; Esvet Akbaş; Ertan Şahin
Journal:  J Fluoresc       Date:  2014-09-13       Impact factor: 2.217

4.  Synthesis of Novel Benzazole Derivatives and Evaluation of Their Antidepressant-Like Activities with Possible Underlying Mechanisms.

Authors:  Gamze Tokgöz; Ümide Demir Özkay; Derya Osmaniye; Nazlı Turan Yücel; Özgür Devrim Can; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2018-11-05       Impact factor: 4.411

5.  Experimental and theoretical studies of new Co(III) complexes of hydrazide derivatives proposed as multi-target inhibitors of SARS-CoV-2.

Authors:  Sakineh Parvarinezhad; Mehdi Salehi; Maciej Kubicki; Rahimeh Eshaghi Malekshah
Journal:  Appl Organomet Chem       Date:  2022-08-08       Impact factor: 4.072

6.  Synthesis and Antidepressant Activity Profile of Some Novel Benzothiazole Derivatives.

Authors:  Ümide Demir Özkay; Ceren Kaya; Ulviye Acar Çevik; Özgür Devrim Can
Journal:  Molecules       Date:  2017-09-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.